| Study |
Summary of Significant Findings (Patient Reported Outcomes) |
| Zigler and Delamarter, 2012 [19] |
Significantly lower scores for pain intensity (p = 0.0122) and frequency (p = 0.0263) in the BRYAN than fusion group at the 5-year follow-up for VAS neck pain score. |
| Zhang et al., 2012 [12] |
VAS neck pain score was significantly better in BRYAN group relative to fusion group at 24 months follow ups (p = 0.013). |
| Cheng et al., 2011 [13] |
Return to work was significantly sooner in BRYAN patients at all time points. (p<0.01). NDI score was significantly better in BRYAN group than fusion patients at 24 months and 36-month follow-ups. (p<0.05) SF-36 PCS was significant better in BRYAN group than fusion patients at 12, 24 and 36-month follow ups. (p<0.05) JOS was significantly better in BRYAN group than fusion patients at 36-month follow-ups. (p<0.05) |
| Sasso et al., 2011 [14] |
NDI was significantly better in BRYAN group at 1.5, 3, 6, 12, 24, 48-month relative to ACDF (p<0.05). Improvements in arm pain score significantly favored BRYAN over fusion group at 12 and 48-month (p<0.05). Neck pain scores was significantly better in BRYAN than fusion group at 1.5, 3, 6, 12, 24, 48-month follow-up (p<0.05). SF-36 PCS*: Significantly better in BRYAN than fusion group at 1.5, 3, 6, 12, 48-month follow-ups. (p<0.02) Overall Success*: Significantly higher in BRYAN than fusion group at 1.5, 3, 6, 12, 48-month follow-ups. (p<0.02) |
| Coric et al., 2011 [18] |
Rate of Overall Success*: Significantly higher at the 24 month follow up. (p = 0.05) |
| Burkus et al., 2010 [16] |
NDI*: Significantly better NDI scores in PRESTIGE group compared to fusion patients at 1.5, 3, 36, 60-month follow-ups. (p<0.05) SF-36 PCS*: Significantly better SF-36 scores in PRESTIGE group at 36-month follow-up. (p = 0.038) Neck pain score*: Significantly better in PRESTIGE group compared to fusion patients at 1.5, 3, 12, 36-month follow-ups. |
| Porchet and Metcalf, 2004 [15] |
No significant findings detected |
|
